Literature DB >> 28289058

What Is Wrong with Pertussis Vaccine Immunity? Inducing and Recalling Vaccine-Specific Immunity.

Christiane S Eberhardt1,2, Claire-Anne Siegrist1,3.   

Abstract

The high incidence of pertussis in vaccinated adolescents suggests the failing of immune memory. We argue that acellular pertussis vaccines generate memory cells that are effectively reactivated by boosters better than by Bordetella pertussis exposure. We propose that there are two main causes. One is the induction of vaccine-specific immunity rather than pathogen-specific immunity. The second is that strictly mucosal infections such as B. pertussis poorly reactivate memory B and T cells residing deep in lymph nodes or tissues. Developing new vaccines for infants or adolescents will be immunologically and economically challenging. Let us hope that maternal and infant immunization, to date the most effective strategies against pertussis death, will remain so.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28289058      PMCID: PMC5710108          DOI: 10.1101/cshperspect.a029629

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  69 in total

1.  Immunity to pertussis 5 years after booster immunization during adolescence.

Authors:  Kati Edelman; Qiushui He; Johanna Mäkinen; Anna Sahlberg; Marjo Haanperä; Lode Schuerman; Joanne Wolter; Jussi Mertsola
Journal:  Clin Infect Dis       Date:  2007-04-02       Impact factor: 9.079

Review 2.  Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.

Authors:  Nicolas Hegerle; Nicole Guiso
Journal:  Expert Rev Vaccines       Date:  2014-06-23       Impact factor: 5.217

3.  Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory?

Authors:  Klara M Posfay-Barbe; Marie Kobela; Cedric Sottas; Stéphane Grillet; Jean Taguebue; Tetanye Ekoe; Paul-Henri Lambert; Claude Lecoultre; Claire-Anne Siegrist
Journal:  Vaccine       Date:  2010-05-04       Impact factor: 3.641

Review 4.  Bordetella pertussis fimbriae (Fim): relevance for vaccines.

Authors:  Andrew R Gorringe; Thomas E Vaughan
Journal:  Expert Rev Vaccines       Date:  2014-08-08       Impact factor: 5.217

5.  Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.

Authors:  S A Halperin; B Smith; M Russell; D Scheifele; E Mills; P Hasselback; C Pim; W Meekison; R Parker; P Lavigne; L Barreto
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

Review 6.  Development of improved pertussis vaccine.

Authors:  Martin Rumbo; Daniela Hozbor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors:  P Olin; F Rasmussen; L Gustafsson; H O Hallander; H Heijbel
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

8.  Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.

Authors:  Maxwell A Witt; Larry Arias; Paul H Katz; Elizabeth T Truong; David J Witt
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

9.  Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates.

Authors:  J M Warfel; T J Merkel
Journal:  Mucosal Immunol       Date:  2012-11-28       Impact factor: 7.313

10.  Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

Authors:  Pádraig J Ross; Caroline E Sutton; Sarah Higgins; Aideen C Allen; Kevin Walsh; Alicja Misiak; Ed C Lavelle; Rachel M McLoughlin; Kingston H G Mills
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more
  10 in total

1.  Genetically detoxified pertussis toxin induces superior antigen specific CD4 T cell responses compared to chemically detoxified pertussis toxin.

Authors:  Naveen Surendran; Michael Pichichero
Journal:  Hum Vaccin Immunother       Date:  2019-03-19       Impact factor: 3.452

2.  Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries.

Authors:  Pauline Versteegen; Alex-Mikael Barkoff; Marta Valente Pinto; Jan van de Kasteele; Aapo Knuutila; Sagida Bibi; Lia de Rond; Johanna Teräsjärvi; Katherine Sanders; Mary-Lène de Zeeuw-Brouwer; Raakel Luoto; Hinke Ten Hulscher; Elizabeth A Clutterbuck; Elisabeth A M Sanders; Jussi Mertsola; Guy A M Berbers; Qiushui He; Dominic F Kelly; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

3.  Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.

Authors:  María Emilia Gaillard; Daniela Bottero; María Eugenia Zurita; Francisco Carriquiriborde; Pablo Martin Aispuro; Erika Bartel; David Sabater-Martínez; María Sol Bravo; Celina Castuma; Daniela Flavia Hozbor
Journal:  Front Immunol       Date:  2017-09-06       Impact factor: 7.561

Review 4.  First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines.

Authors:  Francesco Borriello; Simon D van Haren; Ofer Levy
Journal:  mSphere       Date:  2018-08-01       Impact factor: 4.389

Review 5.  A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for Mycobacterium tuberculosis and Bordetella pertussis.

Authors:  Yuan Tian; Ricardo da Silva Antunes; John Sidney; Cecilia S Lindestam Arlehamn; Alba Grifoni; Sandeep Kumar Dhanda; Sinu Paul; Bjoern Peters; Daniela Weiskopf; Alessandro Sette
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

6.  Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.

Authors:  Pablo Martin Aispuro; Nicolás Ambrosis; María Eugenia Zurita; María Emilia Gaillard; Daniela Bottero; Daniela Flavia Hozbor
Journal:  Front Microbiol       Date:  2020-04-17       Impact factor: 5.640

7.  TLR agonist combinations that stimulate Th type I polarizing responses from human neonates.

Authors:  Naveen Surendran; Andrea Simmons; Michael E Pichichero
Journal:  Innate Immun       Date:  2018-04-19       Impact factor: 2.680

Review 8.  Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines.

Authors:  Anja Saso; Beate Kampmann; Sophie Roetynck
Journal:  Vaccines (Basel)       Date:  2021-08-07

9.  Protection against Pertussis in Humans Correlates to Elevated Serum Antibodies and Memory B Cells.

Authors:  Valentina Marcellini; Eva Piano Mortari; Giorgio Fedele; Francesco Gesualdo; Elisabetta Pandolfi; Fabio Midulla; Pasqualina Leone; Paola Stefanelli; Alberto Eugenio Tozzi; Rita Carsetti
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

10.  Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

Authors:  Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.